I think what @Farr23 is doing there, with the appropriate amount of sarcasm, is pointing out the ridiculous nature of Jimmy's post.
As Jimmy notes over on the BRN threads, commercialisation takes a considerable amount of time, effort and capital. So whilst Jimmy is prepared to acknowledge this is acceptable for a software company, he seems unwilling to concede the same point for a biotech - one which is currently engaged in product development aimed at saving lives.
BIT036- a likely candidate for curing COVID-19, page-698
-
- There are more pages in this discussion • 1,369 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
